Preoperative GLP-1 agonist use is not associated with perioperative aspiration or pneumonia: an observational study using US national data
NEW DELHI: In good news for those suffering from obstructive sleep apnea (OSA), a condition characterised by disordered breathing during sleep, the US FDA has, for the first time, approved an anti-diabetic drug also used for weight loss, sold under the brand name Zepbound (Tirzepatide), to manage the condition in adults with obesity.Treatments currently for moderate to severe OSA involve using assistive breathing devices such as CPAP and Bi-Pap
12-Month Plan $183/mo
Any update here can reset the narrative
Gastrointestinal distress is a commonly reported side effect of GLP-1s, impacting roughly 40% to 70% of patients
The best standard for sensitive skin: Free of the top common allergy causing ingredients Free of added potentially harmful hormone-altering chemicals and ingredients that may affect teen development such as Phthalates, Bisphenols, Parabens, halogenated phenols (such as Triclosan), Benzophenone-3, Perfluoro (PFAS) compounds, hexylresorcinol, and related ingredients